Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9191511rdf:typepubmed:Citationlld:pubmed
pubmed-article:9191511lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0542269lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0004147lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0012373lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0016018lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0681698lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C1414461lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0687676lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0023981lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0175668lld:lifeskim
pubmed-article:9191511lifeskim:mentionsumls-concept:C0719166lld:lifeskim
pubmed-article:9191511pubmed:issue11lld:pubmed
pubmed-article:9191511pubmed:dateCreated1997-7-7lld:pubmed
pubmed-article:9191511pubmed:abstractTextTo describe the rationale and design of the Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT).lld:pubmed
pubmed-article:9191511pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9191511pubmed:languageenglld:pubmed
pubmed-article:9191511pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9191511pubmed:citationSubsetIMlld:pubmed
pubmed-article:9191511pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9191511pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9191511pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9191511pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9191511pubmed:statusMEDLINElld:pubmed
pubmed-article:9191511pubmed:monthNovlld:pubmed
pubmed-article:9191511pubmed:issn0828-282Xlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:LamJJlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:LangerAAlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:BasuDDlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:GoodmanSSlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:StantonEElld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:HillCClld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:ThompsonCClld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:DoraG LGLlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:WarnicaWWlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:McCannGGlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:HigginsonLLlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:MasseiGGlld:pubmed
pubmed-article:9191511pubmed:authorpubmed-author:NasmithJJlld:pubmed
pubmed-article:9191511pubmed:issnTypePrintlld:pubmed
pubmed-article:9191511pubmed:volume12lld:pubmed
pubmed-article:9191511pubmed:ownerNLMlld:pubmed
pubmed-article:9191511pubmed:authorsCompleteYlld:pubmed
pubmed-article:9191511pubmed:pagination1183-90lld:pubmed
pubmed-article:9191511pubmed:dateRevised2008-4-9lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:meshHeadingpubmed-meshheading:9191511-...lld:pubmed
pubmed-article:9191511pubmed:year1996lld:pubmed
pubmed-article:9191511pubmed:articleTitlePROTECT (Prospective Reinfarction Outcomes in the Thrombolytic Era Cardizem CD Trial): a randomized, double-blind clinical trial of diltiazem versus atenolol in secondary prophylaxis post non-Q wave myocardial infarction.lld:pubmed
pubmed-article:9191511pubmed:affiliationSt Michael's Hospital Clinical Trials Unit, University of Toronto, Ontario. goodmans@smh.toronto.on.calld:pubmed
pubmed-article:9191511pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9191511pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9191511pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9191511pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:9191511pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:9191511pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9191511lld:pubmed